To further characterize the effects of AGX51 in cancer cells, we treated the 4T1 murine mammary cancer cell line with increasing concentrations of AGX51 (0–80 μM) for 24 h and observed a significant decrease in ID1 protein levels starting at 40 μM (Fig. 1a). Here, ID1 is linked to breast cancer.